Workers Fried and Died Under Trump’s Workplace Safety Nominee
As David Keeling led companies’ safety operations, workers fell ill and died amid extreme temperatures. Now he could dismantle federal heat protections.
Archive
Explore all of The Lever’s reporting that holds the powerful accountable.
How Shareholder Payouts Fuel Corporate Profiteering
A new Federal Reserve study says record corporate profit increases are "driven by an increase in the dividends rewarding shareholders.”
Project 2025 Is 28 Percent Complete, Thanks To Trump
The president said he had nothing to do with the right-wing plan to dismantle the federal bureaucracy. Now, Project 2025’s authors are celebrating just how much of their agenda Trump has achieved.
From Harvard To The Humane Society: How Trump Could Weaponize The IRS Against Tax-Exempt Groups
The president is eyeing rescinding the tax-exempt status of nonprofit groups he disagrees with.
The Tech Companies Fighting To Sell Your Data
Companies accused of exposing consumers to fraud and trickery want Trump to let them freely buy and sell your personal information.
How To Get Out Of Jail For (Almost) Free
Former Wells Fargo executives convicted in a $3 billion fraud scheme will get off the hook for pennies after the bank donated to Trump’s inauguration.
LEVER WEEKLY: The Pentagon’s New Powder Room
The government’s adding a makeup studio to the war room, the antitax movement shows some cracks, and more from The Lever this week.
YOU LOVE TO SEE IT: Rewriting The Prescription Playbook
States are cutting out the medicine middleman, an Ivy League college fixes its math, questionable opioid prescriptions are set right, and vacations just got simpler.
Supercharging Musk’s Space Monopoly
Trump regulators could boost the power and number of SpaceX satellites, buttressing a space armada that’s suppressing competition, blinding telescopes, and endangering spaceflight.
For This Insurer, Breathing Now Comes With A Catch
Blue Cross Blue Shield just made it harder for many patients to get vital asthma and allergy medications — all while channeling more profits toward a PBM-affiliated pharmacy.